Faculty of Medicine, Visual Neuroscience Laboratory, Institute of Biomedical Research on Light and Image (IBILI), University of Coimbra, Azinhaga de Santa Comba, Celas, 3000-548 Coimbra, Portugal.
J Neurol. 2011 Sep;258(9):1695-704. doi: 10.1007/s00415-011-6008-y. Epub 2011 Mar 31.
Asymptomatic visual loss is a feature of multiple sclerosis (MS) but its relative impact on distinct retinocortical pathways is still unclear. The goal of this work was to investigate patterns of subclinical visual impairment in patients with MS with and without clinically associated previous optic neuritis (ON). We have used functional methods that assess parvo-, konio- and magnocellular pathways in order to compare pathophysiological mechanisms of damage in a population of 44 subjects with MS (87 eyes), with and without a previous episode of ON. These methods included chromatic contrast sensitivity across multiple chromatic axes (Cambridge Colour Test-parvo/konio pathways), perimetric achromatic contrast sensitivity for the magno pathway [frequency doubling technique (FDT)] and pattern visual evoked potentials (VEP). These measures were correlated with field sensitivity measures obtained using conventional automated static perimetry (ASP) and were also compared with conventional clinical chromatic/achromatic contrast sensitivity chart-based measures. We have found evidence for uncorrelated damage of all retinocortical pathways only in patients with MS without ON. VEP evidence for axonal damage was found in this group supporting the emerging notion of axonal damage even in sub-clinical stages of ON/MS pathophysiology. Only in this group was significant correlation of functional measures with disease stage observed, suggesting that distinct pathophysiological milestones are present before and after ON has occurred.
无症状性视力丧失是多发性硬化症 (MS) 的特征,但它对不同的视网膜通路的相对影响尚不清楚。本研究的目的是调查伴有和不伴有临床相关既往视神经炎 (ON) 的 MS 患者的亚临床视力损害模式。我们使用了功能方法来评估中、小和大细胞通路,以便在 44 名 MS 患者(87 只眼)的人群中比较损伤的病理生理机制,这些患者中有和没有先前的 ON 发作。这些方法包括跨多个色觉轴的色觉对比敏感度(剑桥色觉测试-中、小细胞通路)、大细胞通路的周边非彩色对比敏感度(倍频技术 (FDT))和图形视觉诱发电位 (VEP)。这些测量结果与使用传统自动静态视野计 (ASP) 获得的视野敏感性测量结果相关,并与传统的基于临床色觉/非色觉对比敏感度图表的测量结果进行了比较。我们发现只有在没有 ON 的 MS 患者中,所有视网膜通路的损伤是无关的。在这组患者中发现了 VEP 轴突损伤的证据,这支持了即使在 ON/MS 病理生理学的亚临床阶段也存在轴突损伤的新观点。只有在这组患者中,功能测量与疾病阶段之间存在显著相关性,这表明在 ON 发生前后存在不同的病理生理里程碑。